Back
Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!
Buy
58
REGN
Regeneron Pharmaceuticals
Last Price:
882.92
Seasonality Move:
10.55%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to SeeRegeneron Pharmaceuticals Price Quote
$882.92
-0.28 (-0.87%)
(Updated: April 27, 2024 at 6:18 AM ET)
Regeneron Pharmaceuticals Key Stats
Buy
58
Regeneron Pharmaceuticals (REGN)
is a Buy
Day range:
$875.23 - $887.48
52-week range:
$684.81 - $998.33
Dividend yield:
0%
P/E ratio:
25.40
P/S ratio:
7.66
P/B ratio:
3.73%
Volume:
502.9K
Avg. volume:
457.7K
1-year change:
13.52%
Market cap:
$96.9B
Revenue:
$13.1B
EPS:
$34.75
How Much Does Regeneron Pharmaceuticals Make?
-
How Much Are Regeneron Pharmaceuticals's Sales Annually?
REGN Revenues are $13.1B -
How Much Profit Does Regeneron Pharmaceuticals's Make A Year?
REGN net income is $4B
Is Regeneron Pharmaceuticals Growing As A Company?
-
What Is Regeneron Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.01% -
What Is Regeneron Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.03%
Regeneron Pharmaceuticals Stock Price Performance
-
Did Regeneron Pharmaceuticals Stock Go Up Last Month?
Regeneron Pharmaceuticals share price went down by -8.34% last month -
Did REGN's Share Price Rise Over The Last Year?
REGN share price rose by 13.52% over the past 1 year
What Is Regeneron Pharmaceuticals 52-Week High & Low?
-
What Is Regeneron Pharmaceuticals’s 52-Week High Share Price?
Regeneron Pharmaceuticals has traded as high as $998.33 over the past 52 weeks -
What Is Regeneron Pharmaceuticals’s 52-Week Low Share Price?
Regeneron Pharmaceuticals has traded as low as $684.81 over the past 52 weeks
Regeneron Pharmaceuticals Price To Free Cash Flow
-
Is Regeneron Pharmaceuticals Stock Overvalued?
Regeneron Pharmaceuticals is trading at a price to free cash flow ratio of 27.39 -
Is Regeneron Pharmaceuticals Stock Undervalued?
Regeneron Pharmaceuticals EV to Free Cash Flow ratio is 24.02 -
What Is Regeneron Pharmaceuticals’s Price Earnings Growth Ratio?
REGN PEG ratio is 0.00 -
Is Regeneron Pharmaceuticals Trading At A Premium To Earnings?
Regeneron Pharmaceuticals EV to EBIT ratio is 20.62
Is It Risky To Buy Regeneron Pharmaceuticals?
-
How Much Debt Does Regeneron Pharmaceuticals Have?
Total long term debt quarterly is $2B -
How Much Cash Does Regeneron Pharmaceuticals Have?
Cash and short term investments quarterly total is $10.8B -
What Is Regeneron Pharmaceuticals’s Book Value Per Share?
Book value per share is 237.37
Is Regeneron Pharmaceuticals Cash Flow Positive?
-
What Is REGN Cash Flow From Operations?
Cash flow from operations (TTM) is $4.6B -
What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.8B -
What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$3.2B
Regeneron Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
REGN return on invested capital is 15.09% -
What Is Regeneron Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 12.74% -
What Is REGN Return On Equity?
ROE is a measure of profitability and is 16.33%
Regeneron Pharmaceuticals Earnings Date & Stock Price
-
What Is Regeneron Pharmaceuticals's Stock Price Today?
A single share of REGN can be purchased today for 883.20 -
What Is Regeneron Pharmaceuticals’s Stock Symbol?
Regeneron Pharmaceuticals trades on the S&P500 under the ticker symbol: REGN -
When Is Regeneron Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Regeneron Pharmaceuticals is scheduled on May 2, 2024 -
When Is REGN's next ex-dividend date?
Regeneron Pharmaceuticals's next ex-dividend date is April 28, 2024 -
How To Buy Regeneron Pharmaceuticals Stock?
You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Regeneron Pharmaceuticals Competitors
-
Who Are Regeneron Pharmaceuticals's Competitors?
Below is a list of companies who compete with Regeneron Pharmaceuticals or are related in some way:
Regeneron Pharmaceuticals Dividend Yield
Data Unavailable
Regeneron Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -2.95% | 10.37% |
| Revenue: | 0.58% | 4.49% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 7 |
| Sell Recommendations: | 0 |
| Price Target: | 1,038.08 |
| Upside from Last Price: | 17.54% |